The AIM-HI Beacon Award for Women Leaders in Oncology recognizes outstanding women leaders in all sectors of the health and life sciences industry who have made a significant impact on advancing cancer treatment, detection, and diagnosis for patients worldwide through the development and commercialization of novel technologies, advocacy, and/or implementation of public policy. The Nomination Deadline for the 2024 Beacon Award is Friday, May 31, 2024, at 11:55 PM Eastern time.

The 2024 Beacon Award prize recipient will be honored and awarded an authentic gold medal at a Luncheon Award Ceremony at the National Press Club in Washington DC on October 18, 2024. All nomination information will be kept confidential, and be reviewed and evaluated by the distinguished Beacon Award Selection Committee, comprising of physician-scientists, successful entrepreneurs, and prominent business leaders in the health & life sciences industry. Nominations will be assessed according to the following criteria:

• Sustained commitment and leadership for cancer research, development and commercialization of innovative products
• Advocacy for and implementation of public policy to benefit cancer patients
• Encouragement, advocacy and inspiration of other women
• Impact on cancer patients, their families and community